Carbamazepine--indinavir interaction causes antiretroviral therapy failure.
about
Neuropsychiatric manifestations of HIV infection and AIDSRole of therapeutic drug monitoring for protease inhibitors.Mechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir.Anticonvulsant and antiretroviral interactions.Clinically relevant drug interactions with antiepileptic drugsDrug interactions in the management of HIV infection.Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the InternatiPopulation-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?The role of cytochrome P450 in antiretroviral drug interactions.Drug interactions in the management of HIV infection: an update.Issues in co-morbid severe mental illnesses in HIV infected individuals.Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN.The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C.Pharmaceutical care for HIV patients on directly observed therapy.Prevalence of seizures in children infected with human immunodeficiency virus.Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir.
P2860
Q33868874-AF000839-1BD8-4F16-ACFD-0B747113BE1DQ34284286-BFE4C73D-2373-4F2B-BAA2-8CCC9AE2C7D7Q34633457-87D7CF68-0C7E-40D4-B3C7-BF0D02E00DE7Q35670044-02358446-9277-4069-BEDC-89D14523D157Q35827491-7198809E-A9AB-4FEC-9BC4-2029A4DBE140Q36066083-78290FB9-4245-4052-96AA-5356FF231F88Q36304546-EC6515D4-F982-4B93-8958-33092B2CDB71Q36628026-C0E85499-8886-4DBC-BA01-185E6008DE3FQ36909336-C2088E4B-60D3-45AD-84DA-BFC5D1965DC7Q37000733-67EC1749-FD32-437B-A061-F30BFA178100Q37073680-54E496A9-5E6E-4B43-9CFD-BB2FD0A323F6Q37973439-EF036C28-44B7-4B30-A243-0FDA372CD46FQ38152774-9D88A26C-1BB5-4963-A4F1-CAF61886BC7BQ39677370-1AB64281-D330-4D9A-A3FD-3CC487F85AEEQ45356453-7AEC2477-41E7-4159-A691-166B34764775Q48499508-91F068E5-4E10-433C-9DA7-D6DB21D56636
P2860
Carbamazepine--indinavir interaction causes antiretroviral therapy failure.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Carbamazepine--indinavir interaction causes antiretroviral therapy failure.
@en
Carbamazepine--indinavir interaction causes antiretroviral therapy failure.
@nl
type
label
Carbamazepine--indinavir interaction causes antiretroviral therapy failure.
@en
Carbamazepine--indinavir interaction causes antiretroviral therapy failure.
@nl
prefLabel
Carbamazepine--indinavir interaction causes antiretroviral therapy failure.
@en
Carbamazepine--indinavir interaction causes antiretroviral therapy failure.
@nl
P2093
P2860
P356
P1476
Carbamazepine--indinavir interaction causes antiretroviral therapy failure.
@en
P2093
D M Burger
H J ter Hofstede
K Brinkman
P P Koopmans
R Schuurman
Y A Hekster
P2860
P304
P356
10.1345/APH.19211
P407
P577
2000-04-01T00:00:00Z